arXiv:2511.04333v1 Announce Type: cross
Abstract: Dynamic Bayesian networks (DBNs) are increasingly used in healthcare due to their ability to model complex temporal relationships in patient data while maintaining interpretability, an essential feature for clinical decision-making. However, existing approaches to handling missing data in longitudinal clinical datasets are largely derived from static Bayesian networks literature, failing to properly account for the temporal nature of the data. This gap limits the ability to quantify uncertainty over time, which is particularly critical in settings such as intensive care, where understanding the temporal dynamics is fundamental for model trustworthiness and applicability across diverse patient groups. Despite the potential of DBNs, a full Bayesian framework that integrates missing data handling remains underdeveloped. In this work, we propose a novel Gibbs sampling-based method for learning DBNs from incomplete data. Our method treats each missing value as an unknown parameter following a Gaussian distribution. At each iteration, the unobserved values are sampled from their full conditional distributions, allowing for principled imputation and uncertainty estimation. We evaluate our method on both simulated datasets and real-world intensive care data from critically ill patients. Compared to standard model-agnostic techniques such as MICE, our Bayesian approach demonstrates superior reconstruction accuracy and convergence properties. These results highlight the clinical relevance of incorporating full Bayesian inference in temporal models, providing more reliable imputations and offering deeper insight into model behavior. Our approach supports safer and more informed clinical decision-making, particularly in settings where missing data are frequent and potentially impactful.
OptoLoop: An optogenetic tool to probe the functional role of genome organization
The genome folds inside the cell nucleus into hierarchical architectural features, such as chromatin loops and domains. If and how this genome organization influences the


